Cybercitizen Health® Overview

August 27, 2016

Data and insights to create multichannel patient experiences that drive results

DRG Digital’s Cybercitizen Health® research, insights and advisory services help pharma brands:

  • Understand needs and digital behavior across the patient journey
  • Identify opportunities for pharma to play in remote care and telehealth
  • Plan multichannel and social experiences tailored for specific patient audiences

Coverage for 5 countries and 50+ disease states

 


Our analysts provide brands answers to questions such as:

  • Digital patient journey: How do consumers leverage online resources along the patient journey?
  • Point-of-care dynamics: How do consumers choose their healthcare provider? What activities do they perform online before a doctor’s visit? What is consumer involvement in treatment decisions? 
  • Remote care landscape: What digital communication methods do consumers use to connect with their doctors? What impact does tracking and sharing health measurements with physicians have on consumers’ health management?
  • Telehealth: What is the adoption of telehealth and how are patients using it? What outcomes result from virtual visits and online follow-up materials do patients want?        
  • Social media and health influencers: How does social media impact health decision-making? What type of social content should brands develop, and what type of social health influencers have the most impact on health decisions?
  • Pain points and patient support: What challenges do patients face within the health system? What patient support opportunities should you focus on? 

 

Coverage for some topic areas varies by country


 

  Countries covered:  United States, United Kingdom, France, Germany, Spain, Italy

 

Disease states (US):

Patient, Caregiver & Rx taker segments

  • Acid Reflux
  • Acne
  • ADD/ADHD
  • Age-related Macular Degeneration
  • Allergies
  • Angina
  • Arthritis
  • Osteoarthritis
  •  Rheumatoid arthritis (mild, moderate-severe)
  •  Psoriatic arthritis
  • Parent to child with ankylosing spondylitis
  • Parent to child with juvenile idiopathic arthritis
  • Parent to child with plaque psoriasis
  • Parent to child with Crohn's Disease
  • Arrhythmia
  • Asthma (mild, moderate-severe)
  • Atrial Fibrillation
  • Autism
  • Atopic dermatitis
  • Bipolar Disorder
  • Cancer (diagnosed past 3 years)
  • Breast Cancer
  • Prostate Cancer
  • Skin Cancer
  • Chronic Pain
  • Chronic Bronchitis
  • Chronic kidney disease
  • COPD
 

 

  • Crohn's Disease
  • Cystic Fibrosis
  • Deep Vein Thrombosis
  • Depression
  • Diabetes (T1 & T2)
  • Eczema (mild, moderate-severe)
  • Emphysema
  • Epilepsy
  • Erectile Dysfunction
  • Fibromyalgia
  • Generalized Anxiety Disorder
  • Glaucoma
  • Gout 
  • Growth Hormone Deficiency
  • Heart Attack past 3 years (ages 45+)
  • Heart failure
  • Heart Disease
  • Hepatitis C
  • High Cholesterol
  • HIV or AIDS
  • Insomnia or Sleep Disorder
  • Irritable Bowel Syndrome
  • Low testosterone
  • Migraine
  • Multiple Sclerosis
  • Osteoporosis
  • Organ transplant recipient
  • Overactive Bladder or Urinary Incontinence
  • Overweight or obese (Weight management or obesity for info seekers)
  • Psoriasis (mild, moderate-severe)
  • Stroke
Previous Article
Reaching rare disease patients through digital touchpoints
Reaching rare disease patients through digital touchpoints

Digital touchpoints are an essential part of the rare disease patient experience. Here's how brands can rea...

Next Article
ePharma Consumer® Overview
ePharma Consumer® Overview

×

Learn more about patient multichannel research

First Name
Last Name
Company Name
Phone Number - optional
Ask Us Your Question - optional
Thank you!
Error - something went wrong!